BMJ open

How common is insulin resistance in young people seeking mental health care, and what health factors is it linked to?

Updated

Abstract

9.9% of young people in primary care-based mental health services show signs of insulin resistance with HOMA2-IR scores greater than 2.0.

  • 20.6% of the participants were classified as overweight, and 10.2% as obese.
  • Less than 1% had an abnormal fasting blood glucose level above 6.9 mmol/L.
  • A positive correlation exists between body mass index (BMI) and HOMA2-IR scores (r=0.44, p<0.001).
  • Younger age and higher BMI are significant predictors of HOMA2-IR scores, together accounting for 22% of the variance.
  • Participants in the highest third of HOMA2-IR scores are more likely to be younger, have higher BMIs, and have depression as a primary diagnosis.

Simplified

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

Competing interests: EMS is the Medical Director, Young Adult Mental Health Unit, St Vincent’s Hospital Darlinghurst, Discipline Leader of Adult Mental Health, School of Medicine, University of Notre Dame, Research Affiliate, The University of Sydney and Consultant Psychiatrist. She has received honoraria for educational seminars related to the clinical management of depressive disorders supported by Servier and Eli-Lilly pharmaceuticals. She has participated in a national advisory board for the antidepressant compound Pristiq, manufactured by Pfizer. She was the National Coordinator of an antidepressant trial sponsored by Servier. IBH has been a Commissioner in Australia’s National Mental Health Commission since 2012. He is the Co-director, Health and Policy at the Brain and Mind Centre (BMC) University of Sydney. The BMC operates early intervention youth services at Camperdown under contract to headspace. He has previously led community-based and pharmaceutical industry-supported (Wyeth, Eli Lily, Servier, Pfizer, AstraZeneca) projects focused on the identification and better management of anxiety and depression. He is a Board Member of Psychosis Australia Trust and a member of Veterans Mental Health Clinical Reference group. He was a member of the Medical Advisory Panel for Medibank Private until Oct 2017. He is the Chief Scientific Advisor to, and an equity shareholder in, Innowell. InnoWell has been formed by the University of Sydney and PwC to administer the $30M Australian Government Funded Project Synergy. Project Synergy is a three year program for the transformation of mental health services through the use of innovative technologies. SLN has received honoraria for an educational seminar for Lundbeck. DFH has received honoraria for educational seminars from JanssenCilag and Eli Lilly.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free